Final ProgramCPSA 2012
Transforming Drug Discovery & Development Through Innovation:
Past, Present and Future
October 1 - 4, 2012
Sheraton Bucks County Hotel
Langhorne, PA
Session Synopsis
Thursday, 8:30 am - 10:00 am
Outsourcing: Science, Interaction and Collaboration
Discussion Leader: Jim Shen, Bristol-Myers Squibb
Outsourcing bioanalysis is an established mainstream practice by virtually all major pharmaceutical and biopharmaceutical companies. During the past few years, we have witnessed an insurgence in outsourcing to overseas CROs. CROs in developing countries offer a vast array of potential cost saving opportunities but because of geographical, developmental and culture differences, this decision need to be carefully considered and weighted. Panelists active in bioanalytical analysis outsourcing will offer their views of and experience with:
- Should you consider outsourcing overseas.
- Advantages and disadvantages of outsourcing overseas
- Pitfalls and considerations;
- How to overcome the communication barriers;
Presentations:
The Role of Bioanalytical CRO in the Global Setting
John Lin, Frontage Laboratories
From R&D to Production: Problems Encounted During Assay Transfer for the Quantitation of Clopidogrel Active Metabolites in Human Plasma
Moucun Yuan, PPD
Denny Liu, Tandem Labs
Panelists:
Bruce Stouffer, Bristol-Myers Squibb
Mike Huang, Janssen
Ron Shoup, AIT Bioscience
Return to program